SOLIDARITY Finland Plus Long-COVID

NCT05220280 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

400

Enrollment

OTHER_GOV

Sponsor class

Conditions

Covid19
Coronavirus Disease 2019
SARS-CoV-2 Acute Respiratory Disease

Interventions

DRUG: Imatinib
DRUG: Infliximab

Sponsor

Clinical Urology and Epidemiology Working Group

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]